Best in Biotech 15 Mar 2023
10 immunotherapy companies making waves in 2023
Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is regarded as the father of…
Immunotherapy
- Latest Posts
News and Trends 14 Mar 2023
How the microbiome can predict cancer immunotherapy success
A new study shows antibiotic treatment prior to CAR-T cell therapy is connected to unfavorable treatment outcomes. An international team…
News and Trends 24 Feb 2023
AELIX announces ‘important step towards HIV eradication’
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies for HIV infection, has announced…
News and Trends 16 Feb 2023
Cytovation melanoma study under way
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane immunotherapy,…
ADVERTISEMENT
News and Trends 9 Feb 2023
TILT Biotherapeutics closes €22M financing for oncology immunotherapy trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million ($23.8 million) round. This follows…
News and Trends 7 Feb 2023
Mnemo Therapeutics and Institut Curie studies lead to cancer-specific targets
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies developed at Institut Curie, its…
News and Trends 1 Feb 2023
Next-generation small molecules hold promise for immunotherapy
By Ian B. Walters, chief executive officer and chairman, Portage Biotech In recent years, PD-1/PD-L1 checkpoint antibody therapies have revolutionized…
News and Trends 31 Jan 2023
The next breakthrough in cancer treatment?
In our body, we have an innate immune system and an immune system that is developed throughout life. Part of…
News and Trends 27 Jan 2023
HKUMed uncovers T cell exhaustion factor driving cancer immunotherapy resistance
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has identified an unexpected driver…
News and Trends 20 Jan 2023
Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy
Brenus Pharma and InSphero AG have received a €1.5 million grant for the collaborative project "STC-1010: A First-in-Class Allogeneic Cell…
ADVERTISEMENT
In Depth 20 Dec 2022
Ebvallo approval ushers in off-the-shelf T-cell immunotherapies
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU approval of Atara Biotherapeutics' Ebvallo…
News and Trends 20 Dec 2022
Watch: Valo Therapeutics at Bio-Europe
Valo Therapeutics Oy is a Finnish immunotherapy company developing antigen-coated oncolytic viruses and vaccine vectors as innovative immunotherapy approaches against…
News and Trends 20 Dec 2022
Watch: Mendus interview
Mendus AB is a Swedish company dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving…
News and Trends 19 Dec 2022
Sanofi and Innate Pharma expand natural killer cell deal
Sanofi and Innate Pharma SA have expanded their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3…
News and Trends 14 Dec 2022
ImaginAb launches trial to study neoadjuvant immunotherapy
ImaginAb Inc., in collaboration with Memorial Sloan Kettering Cancer Center (MSK) and Melanoma Research Alliance (MRA), has launched an investigator-initiated…
News and Trends 14 Dec 2022
Etcembly reveals breakthrough in optimizing TCR assets
Etcembly has announced the successful prediction and optimization of multiple T cell receptor (TCR) assets for targeting leukemias and solid…
ADVERTISEMENT
News and Trends 12 Dec 2022
OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data
OSE Immunotherapeutics SA has presented the latest preclinical data on the use of its anti-IL-7 receptor (IL-7R) antagonist OSE-127 for…
News and Trends 9 Dec 2022
Beyond Biotech podcast 25: Center for Global Development, Humacyte, Transgene
This week, we have three interviews. One is from Bio-Europe, a chat with Transgene chief business officer, Steven Bloom, and…
News and Trends 7 Dec 2022
Touchlight and Odimma Therapeutics sign deal to develop personalized cancer therapy
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, has signed a development and supply agreement with…
News and Trends 6 Dec 2022
Pictor receives $5M in funding for Covid antibody test and human and animal portfolios
Pictor, a global leader in immunodiagnostics, has announced a $5 million funding round to help accelerate pipeline product development projects.…